Corticosteroid and long-acting ß-agonist therapy reduces epithelial goblet cell metaplasia.
about
Corticosteroid and long-acting ß-agonist therapy reduces epithelial goblet cell metaplasia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Corticosteroid and long-acting ...... helial goblet cell metaplasia.
@en
Corticosteroid and long-acting ...... helial goblet cell metaplasia.
@nl
type
label
Corticosteroid and long-acting ...... helial goblet cell metaplasia.
@en
Corticosteroid and long-acting ...... helial goblet cell metaplasia.
@nl
prefLabel
Corticosteroid and long-acting ...... helial goblet cell metaplasia.
@en
Corticosteroid and long-acting ...... helial goblet cell metaplasia.
@nl
P2093
P2860
P356
P1476
Corticosteroid and long-acting ...... thelial goblet cell metaplasia
@en
P2093
E D Gordon
H A Boushey
N R Bhakta
P G Woodruff
W E Finkbeiner
P2860
P304
P356
10.1111/CEA.13015
P577
2017-09-26T00:00:00Z